Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73
"We want to understand how extended access affects program operations, and we're going to learn a lot more, but also really use its wisdom for smarter policy in the future." The challenge is that Balance remains voluntary, leaving no guarantee that coverage will continue for all patients, said Kenneth Thorpe, a health policy professor at Emory University
1 , 4 Clinically, MMNSTs may mimic other spinal malignancies or progressive neurological diseases, thus complicating diagnoses
Daniela Hurtado Andrade, an endocrinologist at the Mayo Clinic